IP Library Assignment 026679/0318
Patent Assignment
Reel/Frame 026679/0318

Release of Security Interest

Recorded: 2011-08-01 Pages: 5
Assignor
OSV GLOBAL STRATEGY FUND, LTD.
Executed: 2011-07-27
Assignee
VIRXSYS CORPORATION
200 PERRY PARKWAY, SUITE 1A, GAITHERSBURG, MARYLAND, 20877
Covered Properties (35)
Methods to Prepare Conditionally Replicating Viral Vectors
Patent: 5,885,806 →
Application: 08/758,598 →
Chimeric Rna Molecules Generated by Trans-Splicing
Patent: 6,013,487 →
Application: 08/766,354 →
Method of Using a Conditionally Replicating Viral Vector to Express a Gene
Patent: 5,888,767 →
Application: 08/917,625 →
Methods and Compositions for Use in Spliceosome Mediated Rna Trans-Splicing
Patent: 6,083,702 →
Application: 09/133,717 →
Methods and Compositions for Use in Spliceosome Mediated Rna Trans-Splicing
Patent: 6,280,978 →
Application: 09/158,863 →
Conditionally Replicating Viral Vectors and Their Use
Patent: 6,207,426 →
Application: 09/251,084 →
Methods to Express Genes from Viral Vectors
Patent: 6,114,141 →
Application: 09/251,085 →
Method to Inhibit Replication of Infective Virus
Patent: 6,232,120 →
Application: 09/251,283 →
Genetic Antiviral Agents and Methods for Their Use
Patent: 6,168,953 →
Application: 09/312,322 →
Operator-Assisted Translation System and Method for Unconstrained Source Text
Patent: 6,385,568 →
Application: 09/394,279 →
Lentiviral Vectors
Patent: 6,498,033 →
Application: 09/524,004 →
Methods to Assay Gene Function with Viral Vectors
Patent: 6,410,257 →
Application: 09/562,894 →
Methods for Stable Transduction of Cells with Hiv-Derived Viral Vectors
Patent: 6,627,442 →
Application: 09/653,088 →
Conditionally replicating viral vectors and their use
Application: 10/328,643 →
Publication: US 2004/0224404
Use of Spliceosome Mediated Rna Trans-Splicing to Confer Cell Selective Replication to Adenoviruses
Patent: 7,094,399 →
Application: 10/434,727 →
Publication: US 2004/0038403
Transduction of Primary Cells
Application: 10/587,437 →
Publication: US 2008/0274091
High-Throughput Methods for Identifying Gene Function Using Lentiviral Vectors
Patent: 7,427,474 →
Application: 10/627,940 →
Publication: US 2004/0203017
Trans-Splicing Mediated Photodynamic Therapy
Patent: 7,399,753 →
Application: 10/658,617 →
Publication: US 2004/0132181
Methods for stable transduction of cells with viral vectors
Application: 10/664,331 →
Publication: US 2004/0062756
Increased transduction using ABC transporter substrates and/or inhibitors
Application: 10/839,118 →
Publication: US 2005/0123514
Viral Vectors and Host Cells and Methods of Making and Using Them
Patent: 7,572,906 →
Application: 10/841,291 →
Publication: US 2004/0202999
Vectors Having Cis-Acting Ribozymes to Self-Process Tanscripts and Method for Making and Using Them
Application: 10/847,728 →
Publication: US 2005/0257277
Screening method for identification of efficient pre-trans-splicing molecules
Application: 10/898,748 →
Publication: US 2006/0154257
Regulated Nucleic Acid Expression System
Patent: 8,043,611 →
Application: 11/011,264 →
Publication: US 2006/0121579
Correction of Alpha-1-Antitrypsin Genetic Defects Using Spliceosome Mediated Rna Trans Splicing
Patent: 8,053,232 →
Application: 11/040,634 →
Publication: US 2006/0234247
Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing
Application: 11/041,155 →
Publication: US 2006/0177933
Expression of Apoai and Variants Thereof Using Spliceosome Mediated Rna Trans-Splicing
Patent: 7,968,334 →
Application: 11/141,447 →
Publication: US 2006/0194317
Vector packaging cell line
Application: 11/172,147 →
Publication: US 2006/0003452
Use of spliceosome mediated RNA trans-splicing for immunotherapy
Application: 11/193,682 →
Publication: US 2006/0094110
Use of RNA trans-splicing for generation of interfering RNA molecules
Application: 11/199,917 →
Publication: US 2006/0134658
Use of Rna Trans-Splicing for Antibody Gene Transfer and Antibody Polypeptide Production
Patent: 7,879,321 →
Application: 11/245,835 →
Publication: US 2006/0160182
Targeted Trans-Splicing of Highly Abundant Transcripts for in Vivo Production of Recombinant Proteins
Patent: 7,871,795 →
Application: 11/245,907 →
Publication: US 2006/0172381
Methods and compositions for use in spliceosome mediated RNA trans-splicing
Application: 11/256,585 →
Publication: US 2006/0246422
Antibody Complexes
Application: 11/424,637 →
Publication: US 2007/0036783
Compositions and methods using lentivirus-based vectors for generating immune responses
Application: 11/506,390 →
Publication: US 2006/0281128
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jul 17, 2007
From: INTRONN, LLC
To: INTRONN, INC.
Reel/Frame 019573/0098 →
Assignment of Assignor's Interest Nov 6, 2007
From: INTRONN INC.
To: VIRXSYS CORPORATION
Reel/Frame 020074/0136 →
Corrective Assignment to Correct the Application 09/766,354 Must Be Corrected to 08/766,354, Previously Recorded on Reel 020074 Frame 0136. Assignor(S) Hereby Confirms the Assignments of Patents from Intronn Inc to Virxsys.. Nov 7, 2007
From: INTRONN INC.
To: VIRXSYS CORPORATION
Reel/Frame 020095/0280 →
Security Agreement Feb 25, 2009
From: VIRXSYS CORPORATION
To: OSV GLOBAL STRATEGY FUND, LTD.
Reel/Frame 022320/0364 →
Security Agreement Apr 21, 2009
From: VIRXSYS CORPORATION
To: MIELE, R. PATRICK, MR.; MIELE, VICTORIA E., MRS.
Reel/Frame 022575/0086 →